US Stock MarketDetailed Quotes

ABIO ARCA biopharma

Watchlist
  • 0.000
  • 0.0000.00%
Close Nov 1 09:30 ET
0Market Cap0.00P/E (TTM)

ARCA biopharma Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
(Q3)Sep 30, 2022
Total revenue
0
0
0
0
0
0
0
0
0
0
Operating revenue
--0
--0
--0
--0
--0
--0
--0
--0
--0
--0
Cost of revenue
Gross profit
Operating expense
58.24%3.12M
38.20%2.48M
-31.14%7.3M
2.71%1.59M
-24.10%1.94M
-38.71%1.97M
-45.19%1.8M
-45.20%10.6M
-72.75%1.55M
-45.89%2.55M
Selling and administrative expenses
74.05%2.99M
64.79%2.32M
7.46%6.28M
3.77%1.54M
5.69%1.62M
-0.87%1.72M
28.05%1.41M
6.25%5.85M
-14.49%1.49M
19.56%1.53M
-General and administrative expense
74.05%2.99M
64.79%2.32M
7.46%6.28M
3.77%1.54M
5.69%1.62M
-0.87%1.72M
28.05%1.41M
6.25%5.85M
-14.49%1.49M
19.56%1.53M
Research and development costs
-48.82%130K
-57.69%165K
-78.67%1.01M
-22.95%47K
-68.55%322K
-82.90%254K
-82.10%390K
-65.67%4.75M
-98.45%61K
-70.22%1.02M
Operating profit
-58.24%-3.12M
-38.20%-2.48M
31.14%-7.3M
-2.71%-1.59M
24.10%-1.94M
38.71%-1.97M
45.19%-1.8M
45.20%-10.6M
72.75%-1.55M
45.89%-2.55M
Net non-operating interest income expense
-9.94%444K
5.11%473K
189.93%1.96M
33.96%501K
131.08%513K
584.72%493K
6,328.57%450K
5,092.31%675K
9,250.00%374K
5,450.00%222K
Non-operating interest income
-9.94%444K
5.11%473K
189.93%1.96M
33.96%501K
131.08%513K
584.72%493K
6,328.57%450K
5,092.31%675K
9,250.00%374K
5,450.00%222K
Other net income (expense)
-5K
0
-3K
Other non- operating income (expenses)
----
----
----
----
----
----
----
---5K
--0
---3K
Income before tax
-80.95%-2.68M
-49.26%-2.01M
46.21%-5.34M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
48.63%-9.93M
79.32%-1.17M
50.49%-2.33M
Income tax
Net income
-80.95%-2.68M
-49.26%-2.01M
46.21%-5.34M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
48.63%-9.93M
79.32%-1.17M
50.49%-2.33M
Net income continuous Operations
-80.95%-2.68M
-49.26%-2.01M
46.21%-5.34M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
48.63%-9.93M
79.32%-1.17M
50.49%-2.33M
Minority interest income
Net income attributable to the parent company
-80.95%-2.68M
-49.26%-2.01M
46.21%-5.34M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
48.63%-9.93M
79.32%-1.17M
50.49%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
-80.95%-2.68M
-49.26%-2.01M
46.21%-5.34M
7.24%-1.09M
38.96%-1.42M
52.97%-1.48M
58.86%-1.35M
48.63%-9.93M
79.32%-1.17M
50.49%-2.33M
Basic earnings per share
-80.00%-2.16
-55.56%-1.68
46.38%-4.44
0.00%-0.96
37.50%-1.2
54.55%-1.2
60.87%-1.08
50.36%-8.28
80.00%-0.96
51.52%-1.92
Diluted earnings per share
-80.00%-2.16
-55.56%-1.68
46.38%-4.44
0.00%-0.96
37.50%-1.2
54.55%-1.2
60.87%-1.08
50.36%-8.28
80.00%-0.96
51.52%-1.92
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
Unqualified Opinion
--
--
--
--
--
--
--
(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022(Q3)Sep 30, 2022
Total revenue 0000000000
Operating revenue --0--0--0--0--0--0--0--0--0--0
Cost of revenue
Gross profit
Operating expense 58.24%3.12M38.20%2.48M-31.14%7.3M2.71%1.59M-24.10%1.94M-38.71%1.97M-45.19%1.8M-45.20%10.6M-72.75%1.55M-45.89%2.55M
Selling and administrative expenses 74.05%2.99M64.79%2.32M7.46%6.28M3.77%1.54M5.69%1.62M-0.87%1.72M28.05%1.41M6.25%5.85M-14.49%1.49M19.56%1.53M
-General and administrative expense 74.05%2.99M64.79%2.32M7.46%6.28M3.77%1.54M5.69%1.62M-0.87%1.72M28.05%1.41M6.25%5.85M-14.49%1.49M19.56%1.53M
Research and development costs -48.82%130K-57.69%165K-78.67%1.01M-22.95%47K-68.55%322K-82.90%254K-82.10%390K-65.67%4.75M-98.45%61K-70.22%1.02M
Operating profit -58.24%-3.12M-38.20%-2.48M31.14%-7.3M-2.71%-1.59M24.10%-1.94M38.71%-1.97M45.19%-1.8M45.20%-10.6M72.75%-1.55M45.89%-2.55M
Net non-operating interest income expense -9.94%444K5.11%473K189.93%1.96M33.96%501K131.08%513K584.72%493K6,328.57%450K5,092.31%675K9,250.00%374K5,450.00%222K
Non-operating interest income -9.94%444K5.11%473K189.93%1.96M33.96%501K131.08%513K584.72%493K6,328.57%450K5,092.31%675K9,250.00%374K5,450.00%222K
Other net income (expense) -5K0-3K
Other non- operating income (expenses) -------------------------------5K--0---3K
Income before tax -80.95%-2.68M-49.26%-2.01M46.21%-5.34M7.24%-1.09M38.96%-1.42M52.97%-1.48M58.86%-1.35M48.63%-9.93M79.32%-1.17M50.49%-2.33M
Income tax
Net income -80.95%-2.68M-49.26%-2.01M46.21%-5.34M7.24%-1.09M38.96%-1.42M52.97%-1.48M58.86%-1.35M48.63%-9.93M79.32%-1.17M50.49%-2.33M
Net income continuous Operations -80.95%-2.68M-49.26%-2.01M46.21%-5.34M7.24%-1.09M38.96%-1.42M52.97%-1.48M58.86%-1.35M48.63%-9.93M79.32%-1.17M50.49%-2.33M
Minority interest income
Net income attributable to the parent company -80.95%-2.68M-49.26%-2.01M46.21%-5.34M7.24%-1.09M38.96%-1.42M52.97%-1.48M58.86%-1.35M48.63%-9.93M79.32%-1.17M50.49%-2.33M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders -80.95%-2.68M-49.26%-2.01M46.21%-5.34M7.24%-1.09M38.96%-1.42M52.97%-1.48M58.86%-1.35M48.63%-9.93M79.32%-1.17M50.49%-2.33M
Basic earnings per share -80.00%-2.16-55.56%-1.6846.38%-4.440.00%-0.9637.50%-1.254.55%-1.260.87%-1.0850.36%-8.2880.00%-0.9651.52%-1.92
Diluted earnings per share -80.00%-2.16-55.56%-1.6846.38%-4.440.00%-0.9637.50%-1.254.55%-1.260.87%-1.0850.36%-8.2880.00%-0.9651.52%-1.92
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ----Unqualified Opinion--------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data